(Q39595803)

13 September 2017

Suppressor cell activity after isoprinosine treatment of lymphocytes from normal mice (English)

1 reference

https://api.crossref.org/works/10.1016/0192-0561(79)90048-1

20 November 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(79)90048-1

20 November 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(79)90048-1

20 November 2022

author name string

G. Renoux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95251

20 November 2022

M. Renoux

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95251

20 November 2022

D. Degenne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A95251

20 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=95251

20 November 2022

publication date

1 January 1979

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:0192056179900481?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0192-0561(79)90048-1

https://api.elsevier.com/content/article/PII:0192056179900481?httpAccept=text/plain

20 November 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(79)90048-1

International Journal of Immunopharmacology

20 November 2022

published in

1 reference

13 September 2017

1

1 reference

13 September 2017

239-241

1 reference

13 September 2017

3

1 reference

Isoprinosine as an Immunopotentiator

13 September 2017

4

1 reference

https://api.crossref.org/works/10.1016/0192-0561(79)90048-1

20 November 2022

Identifiers

1 reference

13 September 2017

1 reference